KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $867.0 million.

  • Quest Diagnostics' Net Income towards Common Stockholders rose 7.54% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $844.0 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $867.0 million for FY2024, which is 2.36% up from last year.
  • Latest data reveals that Quest Diagnostics reported Net Income towards Common Stockholders of $867.0 million as of FY2024, which was up 2.36% from $847.0 million recorded in FY2023.
  • Quest Diagnostics' 5-year Net Income towards Common Stockholders high stood at $2.0 billion for FY2021, and its period low was $847.0 million during FY2023.
  • For the 3-year period, Quest Diagnostics' Net Income towards Common Stockholders averaged around $882.7 million, with its median value being $867.0 million (2024).
  • Per our database at Business Quant, Quest Diagnostics' Net Income towards Common Stockholders skyrocketed by 5,384.62% in 2020 and then plummeted by 52.42% in 2022.
  • Yearly analysis of 5 years shows Quest Diagnostics' Net Income towards Common Stockholders stood at $1.4 billion in 2020, then skyrocketed by 42.87% to $2.0 billion in 2021, then slumped by 52.42% to $934.0 million in 2022, then decreased by 9.31% to $847.0 million in 2023, then climbed by 2.36% to $867.0 million in 2024.